Back
Arch Capital Group Vs. Bright Minds Biosciences Industry Stock Comparison
Buy
59
ACGL
Arch Capital Group
Last Price:
99.63
Seasonality Move:
3.33%
Sell
25
DRUG
Bright Minds Biosciences
Last Price:
47.47
Seasonality Move:
-15.89%
Buy
59
Arch Capital Group (ACGL)
is a Buy
Is Arch Capital Group a Buy, Sell or Hold?
- The current Arch Capital Group [ACGL] share price is $100.72. The Score for ACGL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- ACGL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
- The current Bright Minds Biosciences [DRUG] share price is $44.00. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACGL Stock Price Chart
What is Arch Capital Group's stock price today?
-
The Arch Capital Group share price today is $100.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACGL is experiencing slight selling pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $44.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.41 | Sell |
| Relative Strength Index (14 RSI): | 48.16 | Sell |
| Chaikin Money Flow: | -87703 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (97.13 - 103.15) | Buy |
| Bollinger Bands (100): | (97.8 - 111.14) | Sell |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.5 | Buy |
| Relative Strength Index (14 RSI): | 58.93 | Buy |
| Chaikin Money Flow: | 115403 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.12 - 49.42) | Buy |
| Bollinger Bands (100): | (-5.11 - 34.85) | Buy |
ACGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 98.95 | Buy |
| 20-day SMA: | 99.21 | Buy |
| 50-day SMA: | 105.71 | Sell |
| 200-day SMA: | 99.6 | Buy |
| 8-day EMA: | 99.86 | Buy |
| 20-day EMA: | 100.54 | Buy |
| 50-day EMA: | 103.19 | Sell |
| 200-day EMA: | 98.88 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.17 | Buy |
| 20-day SMA: | 42.3 | Buy |
| 50-day SMA: | 28.61 | Buy |
| 200-day SMA: | 8.06 | Buy |
| 8-day EMA: | 39.27 | Buy |
| 20-day EMA: | 39.13 | Buy |
| 50-day EMA: | 31.07 | Buy |
| 200-day EMA: | 12.97 | Buy |
Arch Capital Group Earnings Growth & ACGL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $0.11 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Arch Capital Group Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||